Table 3.
Baseline characteristics of participants excluding the patients with seizure attack before operation.
Variable | Seizure after operation | P value | |
---|---|---|---|
Yes | No | ||
Age (years) at operation | 0.600 | ||
≥60 | 7/43 | 36/43 | |
<60 | 21/105 | 84/105 | |
Gender | 0.257 | ||
male | 5/39 | 34/39 | |
female | 23/109 | 86/109 | |
The course of disease(years) | 0.028 | ||
<1 year | 22/118 | 96/118 | |
1–5years | 4/20 | 16/20 | |
>5 years | 2/10 | 8/10 | |
Maximum cross-sectional area | 0.384 | ||
≤15 | 15/90 | 75/90 | |
>15 | 13/58 | 45/58 | |
Location of tumor | 0.045 | ||
non-skull base location | 33/108 | 75/108 | |
skull base location | 6/40 | 34/40 | |
Multiple tumor | 0.504 | ||
Yes | 2/7 | 5/7 | |
No | 26/141 | 115/141 | |
Adjacent to the cortex | 0.756 | ||
Yes | 17/86 | 69/86 | |
No | 11/62 | 51/62 | |
Peritumoral brain edema | 0.645 | ||
yes | 15/86 | 71/86 | |
no | 10/62 | 52/62 | |
Hydrocephalus | 0.002 | ||
yes | 6/11 | 5/11 | |
No | 22/137 | 115/137 | |
WHO classification | 0.575 | ||
I level | 25/136 | 111/136 | |
II/III level | 3/12 | 9/12 | |
Peritumoral adhesion | 0.440 | ||
yes | 17/99 | 82/99 | |
no | 11/49 | 38/49 | |
AEDs | 0.001 | ||
no | 7/80 | 73/80 | |
Prophylactic AED treatment | 21/68 | 47/68 |